|
|
 |
|
Viewing report
|
|
|
|
EpiVax, Inc. - Strategic SWOT Analysis Review
GlobalData, Aug 2011, Pages: 24
EpiVax, Inc. - Strategic SWOT Analysis Review
Summary
EpiVax, Inc. (EpiVax) is engaged in the development and implementation of computational immunology tools for the biotechnology industry. It provides protein and genome analysis services, vaccine components, and vaccine candidates to researchers, government agencies, universities, and pharmaceutical companies. The company discovers, develops, and commercializes Immunogenicity screening, testing, vaccine design and redesign and protein engineering. EpiVax's pipeline products include Immune modulation, Deimmunization and Biodefence vaccines. The company develops innovative vaccines for infectious diseases like HIV, TB, and hepatitis; generates new therapeutics for cancer and autoimmune diseases, and new protein therapeutics treating cancer and autoimmune diseases. The company is headquartered in Providence Rhode Island, the US.
EpiVax, Inc. Key Recent Developments…
Feb 03, 2011: New Study From Rhode Island Hospital Identifies Potential Vaccine To Prevent Gastritis, Ulcer Disease And Gastric Cancer
GlobalData’s EpiVax, Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.
This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.
Scope
- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – GlobalData’s summarization of the company’s business strategy.
- SWOT analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list of key locations and subsidiaries of the company, including contact details.
Note: Some sections may be missing if data is unavailable for the company.
Reasons to Buy
- Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
- Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
- Understand and respond to your competitors’ business structure and strategies with GlobalData’s detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
- Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.
Customers who bought this item also bought
EpiVax, Inc.-Therapeutic Competitors Report
Cancer Vaccine Partnering Agreements
GeoVax Labs, Inc. (GOVX) - Financial and Strategic SWOT Analysis Review
Autoimmune Technologies, LLC - Product Pipeline Analysis
EpiVax, Inc.-Detailed Product Pipeline
EpiCept Corporation (EPCT) - Financial and Strategic SWOT Analysis Review
Alizyme plc (AZM) - Strategic SWOT Analysis Review
Miraculins Inc. (MOM) - Product Pipeline Analysis
Pacific Edge Limited (PEB) - Product Pipeline Analysis
AlphaVax, Inc. - Product Pipeline Review - Q2 2011
|
|
|
|
